Schedule 13G ownership disclosure
TRAVERE THERAPEUTICS INC
Security class unavailable · CUSIP: 89422G107
Event date: 2020-12-24
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,850,000
- Percent of class
- 5.5800%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-21-000009
- Form type
- SC 13G
- Filer
- ADAGE CAPITAL PARTNERS GP, L.L.C.
- CIK
- CIK 1165408
- Filed
- Jan 04, 2021
- Reporting period
- Dec 24, 2020
- Description
- Schedule 13G beneficial ownership